Sinovac Biotech's coronavirus vaccine conducted in Turkey shows that its efficacy rate is 91.25%, which is far higher than the Brazilian study of the same vaccine has suggested.
On Thursday, a Brazilian study portrayed the efficacy rate of the Chinese vaccine is 50%.Also Read | The global drive to reimagine capitalismSinovac's Covid vaccine trial in TurkeySince September, Turkey has run trials involving more than 3,400 people, according to a televised news conference by Health Minister Fahrettin Koca.
The efficacy rate was determined among roughly half of the participants, he said.Turkey has agreed to purchase 50 million doses of the Sinovac vaccine, with the first shipments expected to begin Sunday.